482 results found

The Measures clarify longstanding ambiguities regarding the scope of permitted telemedicine.

On March 23, 2016, the China Food and Drug Administration ("CFDA") and the National Health and Family Planning Commission jointly promulgated the final revision to the 2004 Medical Device Clinical Studies Rules...

A recent criminal judgment published by the Gao'an People's Court in Jiangxi province (江西省高安市人民法院) in June 2025 has drawn public attention to Jiangxi Baishen Pharmaceutical Co.

The Center for Drug Evaluation ("CDE") in China recently published the draft Guidelines for the Administration of Post-Market Studies on Chemical Drugs and Therapeutic Biologics ("Draft Guidelines") for public comments through November 21, 2013.

China has always placed a priority on ensuring food security.

The US Department of Health and Human Services has launched Operation TrialBlazer to address China's growing dominance in clinical research and restore American leadership in biomedical innovation. As Chinese clinical trials now surpass US trials in both speed and volume, this comprehensive initiative aims to modernize regulatory processes, reduce administrative burdens, and reverse the trend of research investment flowing overseas.

Beijing Intellectual Property Court has agreed to hear the case, which is of note as China's first case of patent linkage.

The major texts of these drafts appear to be a set of rules from those of the Chinese courts, detailing the mechanism for accepting and the downstream handling of an infringement complaint.

Thanks for the heads up from Aaron Wininger of Schwegman Lundberg & Woessner, the first drug patent linkage decision has been decided by the Beijing IP Court.

These documents provide specific operational guidelines for the newly established early settlement mechanism for drug patent disputes.

Pharmaceutical companies with service inventions in China should review agreements to ensure there are no ambiguities.

北京知识产权法院审理全国首例药品专利链接诉讼案件.

2022년 3월 14일, 중국 최고인민검찰원(最高人民检察院)...

In our previous article, Code of Conduct for Online Livestreaming Marketing Issued in China, we summarized the key points of the Code of Conduct for Online Livestreaming Marketing in China issued by the CAA on June 24, 2020 ...

The Chinese State Council recently announced the draft amendment of the Food Safety Law ("Draft Amendment") for public comments through November 29, 2013

Chinese authorities have launched a special "Hundred-Day Campaign" to target misconduct relating to China's state-run medical insurance program and issued a new Ethical Code for Healthcare Professionals...

Various blacklist systems are being implemented in a number of areas of Chinese administration, and from 1 October 2012 there will be a blacklist system in place for pharmaceutical security.